Bacteremia Due to Staphylococcus Aureus clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18-90

    This study evaluates safety and tolerability of endolysin-derived LSVT-1701 (tonabacase) as an add-on to standard of care (SOC) antibiotic therapy for the treatment of patients with complicated Staphylococcus aureus bacteremia (SAB), including left- and right-sided infective endocarditis (IE).

    Butte, Montana

Last updated: